Invesaro

Stocks Comparison

agilon health vs Cryo Cell International: revenue, profit, margins and growth compared

agilon health brought in $5.9B of revenue in fiscal 2025, Cryo Cell International $31.6M in fiscal 2025. Revenue changed by -2.1% at agilon health and -1.3% at Cryo Cell International on the year before, so Cryo Cell International grew faster. agilon health kept -6.6% of its revenue as net profit, Cryo Cell International -7.7%. Free cash flow was -$119M at agilon health and $5.2M at Cryo Cell International.

Side by side, latest fiscal year

AGLCCEL
Fiscal year endedFY2025 (December 31, 2025)FY2025 (November 30, 2025)
Revenue$5.9B$31.6M
Revenue growth-2.1%-1.3%
Net income-$391.3M-$2.4M
Net margin-6.6%-7.7%
Free cash flow-$119M$5.2M
Free cash flow margin-2.0%16.6%
Earnings per share (diluted)n/a-$0.30
Cash$173.7M$319K
Debt$35M$8.4M
Price to earningsn/an/a
Market value$1.4B$34.2M
Dividend yieldn/an/a
Rank by revenue in sector#58 of 646 · Health care#412 of 646 · Health care

Over the years

Revenue
AGL FY2019: $794.4MAGL FY2021: $1.2BAGL FY2021: $1.5BAGL FY2022: $2.4BAGL FY2023: $4.3BAGL FY2024: $6.1BAGL FY2025: $5.9BCCEL FY2018: $29.2MCCEL FY2019: $31.8MCCEL FY2020: $31.1MCCEL FY2021: $28.9MCCEL FY2022: $30.3MCCEL FY2023: $31.3MCCEL FY2024: $32MCCEL FY2025: $31.6MFY18FY19FY20FY21FY22FY23FY24FY25
AGL $5.9BCCEL $31.6M
Net income
AGL FY2019: -$282.6MAGL FY2021: -$60.1MAGL FY2021: -$406.5MAGL FY2022: -$106.6MAGL FY2023: -$262.6MAGL FY2024: -$260.2MAGL FY2025: -$391.3MCCEL FY2018: -$854.8KCCEL FY2019: $2.3MCCEL FY2020: $3.6MCCEL FY2021: $2.1MCCEL FY2022: $2.8MCCEL FY2023: -$9.5MCCEL FY2024: $402.1KCCEL FY2025: -$2.4MFY18FY19FY20FY21FY22FY23FY24FY25
AGL -$391.3MCCEL -$2.4M
Net margin
AGL FY2019: -35.6%AGL FY2021: -4.9%AGL FY2021: -26.7%AGL FY2022: -4.5%AGL FY2023: -6.1%AGL FY2024: -4.3%AGL FY2025: -6.6%CCEL FY2018: -2.9%CCEL FY2019: 7.2%CCEL FY2020: 11.6%CCEL FY2021: 7.2%CCEL FY2022: 9.1%CCEL FY2023: -30.4%CCEL FY2024: 1.3%CCEL FY2025: -7.7%FY18FY19FY20FY21FY22FY23FY24FY25
AGL -6.6%CCEL -7.7%
Revenue growth
AGL FY2021: +53.4%AGL FY2021: +24.9%AGL FY2022: +57.0%AGL FY2023: +80.7%AGL FY2024: +40.4%AGL FY2025: -2.1%CCEL FY2019: +8.9%CCEL FY2020: -2.1%CCEL FY2021: -7.3%CCEL FY2022: +5.0%CCEL FY2023: +3.3%CCEL FY2024: +2.0%CCEL FY2025: -1.3%FY19FY20FY21FY22FY23FY24FY25
AGL -2.1%CCEL -1.3%
Free cash flow
AGL FY2019: -$106.8MAGL FY2021: -$55MAGL FY2021: -$154.7MAGL FY2022: -$146.2MAGL FY2023: -$172MAGL FY2024: -$71MAGL FY2025: -$119MCCEL FY2018: $4.9MCCEL FY2019: $5.6MCCEL FY2020: $8.4MCCEL FY2021: $6.1MCCEL FY2022: -$3.6MCCEL FY2023: $2.1MCCEL FY2024: $3.6MCCEL FY2025: $5.2MFY18FY19FY20FY21FY22FY23FY24FY25
AGL -$119MCCEL $5.2M

Fiscal years as each company reports them; the two may end in different months.

Questions about agilon health and Cryo Cell International

Which is bigger by revenue, agilon health or Cryo Cell International?

agilon health is bigger by revenue: $5.9B in fiscal 2025, against $31.6M for Cryo Cell International in fiscal 2025.

Which keeps more of its revenue as profit, agilon health or Cryo Cell International?

agilon health had a net margin of -6.6% in fiscal 2025; Cryo Cell International had -7.7% in fiscal 2025.

Which grew revenue faster, agilon health or Cryo Cell International?

In their latest fiscal years revenue changed by -2.1% at agilon health and -1.3% at Cryo Cell International.

Where do these numbers come from?

From the annual reports each company files with the SEC (10-K, or 20-F and 40-F for foreign companies), read from their XBRL data. Margins and growth are simple arithmetic on those figures. Nothing here is a recommendation.

More comparisons

Compare more companies